Trials / Conditions / Rectal Mucinous Adenocarcinoma
Rectal Mucinous Adenocarcinoma
4 registered clinical trials studyying Rectal Mucinous Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or NCT01802320 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer NCT01198535 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Ca NCT00745134 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer NCT00068692 | National Cancer Institute (NCI) | Phase 3 |